Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.460
-0.060 (-2.38%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $177.64 million as of April 28, 2026. Its market cap has increased by 187.52% in one year.
Market Cap
177.64M
Enterprise Value
92.09M
1-Year Change
187.52%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $177.64M, a decrease of -71.28%. That is a compound annual growth rate of -22.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 181.98M | 42.38% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 188.16M |
| Canton Strategic Holdings | 186.97M |
| Korro Bio | 184.61M |
| Precision BioSciences | 183.20M |
| Unicycive Therapeutics | 180.95M |
| Tonix Pharmaceuticals Holding | 180.55M |
| Cartesian Therapeutics | 180.26M |
| Corbus Pharmaceuticals Holdings | 174.17M |